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Purpose: Elevated levels of lipoprotein(a) [Lp(a)] and homocysteine (Hcy) have been implicated as risk factors for
vascular diseases. The study was performed to explore the possible relationship between retinal arteriosclerosis and serum
Lp(a) and Hcy levels.
Methods: Study subjects consisted of 80 nonsmoking male patients with retinal arteriosclerosis and 54 healthy nonsmoker
males as controls. Retinal arteriosclerosis was graded according to the Scheie classification. Serum levels of lipids,
lipoproteins, Lp(a), and Hcy were measured by standard methods.
Results: The serum level of Hcy was higher in patients (24.2±8.1 μmol/l) than controls (10.5±4.1 μmol/l); p<0.01. Serum
levels of Lp(a) in patients (47.9±33.1 mg/dl) was also higher than controls (11.7±7.6 mg/dl); p<0.01. There was a
significant direct linear correlation between the degree of retinal arteriosclerosis and Lp(a) level (r=0.61, p<0.01), the
degree of retinal arteriosclerosis and Hcy level (r=0.72, p<0.01), and also between Lp(a) and Hcy levels (r=0.67, p<0.01).
Conclusions: The association between retinal arteriosclerosis and serum Lp(a) and Hcy levels suggests that Lp(a) as well
as Hcy could play a role in the development of retinal arteriosclerosis.
Arteriosclerotic  retinopathy  involves  vessel  walls  by
medial layer hypertrophy, hyalinization in the intima, and
hyperplasia  in  the  endothelial  layer  [1].  Arteriosclerotic
retinopathy usually occurs as a result of progressive hardening
of blood vessels by calcification and loss of elastic tissue.
Ophthalmoscopic  examination  is  widely  used  in  clinical
practice to examine the presence and the degree of arteriolar
retinopathy, and offers a unique noninvasive opportunity to
assess the status of systemic arteriosclerosis [2,3]. The retinal
arteriole  shares  similar  anatomic  and  physiologic
characteristics with cerebral and coronary microcirculation.
Therefore, retinal microvascular disease may also reflect the
presence  of  systemic  microvascular  disease  [2,4].  Factors
such as smoking, inflammation, and oxidative stress that are
associated with free radical formation have been identified as
possible risk factors for both systemic atherosclerosis and
arteriolar retinopathy [5,6]. Hyperlipidemia is a powerful risk
factor  for  atherosclerosis  and  related  disorders  such  as
ischemic heart disease, cerebrovascular diseases, and retinal
atherosclerosis [7,8]. Although recent studies have shown that
lipoprotein(a) [Lp(a)] and total homocysteine (Hcy) may be
implicated in the development of systemic arteriosclerosis,
little knowledge exists about their role in the pathophysiology
of retinal arteriosclerosis [9-11].
Lp(a) particles contain the lipid and protein component
of low-density lipoprotein (LDL) plus a glycoprotein known
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as apolipoprotein(a) [apo(a)] [12]. Apo(a) is homologous to
plasminogen, and its similarity to plasminogen indicates a
prothrombogenic role for Lp(a), whereas the similarity of
Lp(a) to LDL suggests a proatherogenic role [13]. Serum
Lp(a) concentrations are highly heritable. It is reported that
about 90% of determinant factors are genetically dependent
on sequences of the apo(a) gene in chromosome 6q26–27
[14,15]. Numerous studies have shown that serum levels of
Lp(a) above 30 mg/dl is genetically determined and could be
an independent risk factor for atherosclerotic vascular disease
[16,17].
Both  clinical  and  experimental  investigations  suggest
that  elevated  fasting  serum  Hcy  concentration  also  is  an
independent  risk  factor  for  atherosclerosis,  including
coronary  artery  disease,  peripheral  vascular  disease,
cerebrovascular disease, and venous thromboembolism [18,
19].  Although  the  exact  implication  of  increased  Hcy  on
atherosclerosis  is  not  clear,  recent  studies  indicate  that
15-30% of patients with premature occlusive vascular disease
have moderately elevated Hcy concentrations (higher than 15
μmol/l)  [19].  To  date,  little  information  exists  on  the
possibility that elevated Hcy might increase the risk of retinal
arteriosclerosis.
We  proposed  that  elevated  Lp(a)  and  Hcy  levels
synergistically  increase  the  atherogenic  process,  as  the
potential biochemical interactions with the two risk factors
have already been reported [11,20].
Although Lp(a) and Hcy levels are higher in systemic
atherosclerosis, their relationship with retinal arteriosclerosis
still is not clear [21-23]. The aim of this study was to assess
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1692the serum concentration of lipids and lipoproteins as well as
investigate the concentrations of Hcy and Lp(a) and their
relationship with retinal arteriosclerosis.
METHODS
This case-control study was performed from July, 2005 to
May,  2006  in  the  Retina  service,  Department  of
Ophthalmology of Tabriz University of Medical Sciences. All
participants were recruited from male patients presenting for
routine eye examination at the Tabriz Nikookari Eye Hospital.
Females  were  excluded  from  the  study  as  it  has  been
hypothesized that there is a close relationship between serum
estrogen and Hcy levels [24,25]; in addition, the influence of
sex  hormones  on  Hcy  concentration  is  not  conclusive
[26-29]. The ethic committee at Tabriz University of Medical
Sciences reviewed and approved the present study which is in
compliance with the Declaration of Helsinki.
This study enrolled 80 men with retinal arteriosclerosis
and a control group of 54 healthy males. All participants gave
informed consent. Each participant was evaluated by a retinal
Figure 1. Relationship between Hcy level and the degree of retinal
arteriosclerosis. There was a direct linear correlation between Hcy
level and the degree of retinal arteriosclerosis in the study population
(r=0.72,  p<0.01),  i.e.  patients  with  higher  degree  of  retinal
arteriosclerosis had higher level of Hcy.
specialist (A.J.). Retinal arteriosclerosis was confirmed by
slit-lamp  examination  with  super-field  lens  and  fundus
photography (Image net 2000, Topcon TRC50IX, Topcon
Corp,  Tokyo,  Japan).  Retinal  arteriosclerosis  was  graded
according  to  the  Scheie  classification  for  arteriosclerosis
(Table 1) [30,31]. In addition to female patients, also excluded
were  patients  who  were  being  treated  with  vitamins,
antioxidants, micronutrients supplements, or lipid-lowering
drugs; patients who had active systemic infection; smokers;
and patients who had a history of alcohol abuse, coronary heart
diseases, uncontrolled hypertension (systolic blood pressure
≥140 mmHg, diastolic blood pressure ≥90 mmHg), diabetes
mellitus, thyroid, or other metabolic diseases. All participants
had normal renal and liver functions as assessed by plasma
urea,  creatinine,  alanine  aminotransferase,  and  aspartate
aminotransferase.  Blood  samples  were  obtained  after  an
overnight fasting. Serum samples were frozen immediately
and stored at -70 °C until needed for analysis. Serum levels of
total  cholesterol  (TC),  triglyceride  (TG),  high-density
lipoprotein  cholesterol  (HDL-C)  were  determined  using
commercial reagents with an automated chemical analyzer
(Abbott analyzer, Abbott laboratories, Abbott Park, North
Chicago, IL). Low-density lipoprotein cholesterol (LDL-C)
was calculated by using the Friedewald equation [32]. The
serum level of Lp(a) was assayed by commercially available
immunoturbidimetric kit (Pars Azmun, Tehran, Iran, Lott No:
85001) using the same analyzer. Serum Hcy concentration
was determined by a commercially available enzyme-linked
immunoassay  (Axis-Shield,  Axis  Biochemicals  ASA,
Distributed by IBL, Hamburg, Germany, Cat. No: AX51301).
SPSS software package version 13 for Windows (SPSS
Ins, Chicago, IL) was used to perform statistical analysis.
Results  were  expressed  as  mean  ±  standard  deviation.
Independent t-test, Mann–Whitney U, logistic and multiple
regression  tests,  as  appropriate,  were  used  to  assess
significance  of  differences  between  the  two  groups.  The
correlations between variables were evaluated by Pearson (for
parametric data) or Spearman (for nonparametric data) test as
appropriate.  A  p<0.05  was  considered  significance
statistically.
RESULTS
We  compared  a  group  of  80  male  patients  with  retinal
arteriosclerosis to 54 male control patients. There were no
TABLE 1. SCHEIE   CLASSIFICATION
Stage Observation
0 Normal
1 There is broadening of the light reflex from the arteriole, with minimal or no arteriolovenous compression.
2 Light reflex changes and crossing changes are more prominent.
3 The arterioles have a copper wire appearance, and there is more arteriolovenous compression.
4 The arterioles have a silver wire appearance, and the arteriolovenous crossing changes are most severe.
Retinal arteriosclerosis was graded by slit-lamp with super-field lens and fundus photography in retina according to Scheie
classification as above [30,31].
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1693statistically significant differences between the mean ages of
case (64.3±6.8 years) and control (66.7±8.0 years) groups
(p>0.05). There was no significant difference in systolic blood
pressure between the case (116.90±10.47 mmHg) and control
groups (113.55±10.12 mmHg); p>0.05. Also diastolic blood
pressure  in  the  case  group  (69.81±8.50  mmHg)  was  not
statistically different from control group (67.85±8.05 mmHg);
p>0.05.
All controls had degree 0 of retinal arteriosclerosis (by
slit-lamp with super-field lens and fundus photography in
retina according to Scheie classification in Table 1), while 24
(30%) of patients were affected with degree I, 21 (26.25%)
with degree II, 21 (26.25%) with degree III, and 14 (17.5%)
with degree IV.
Lipid profile of patients and control group are shown in
Table 2. There were no differences in HDL levels between the
two groups, while the mean levels of TG, TC, and LDL were
significantly higher in patients than those in control group.
Serum level of Hcy was higher in patients (24.2±8.1 μmol/l)
than controls (10.5±4.1 μmol/l); p<0.01. Serum levels of
Lp(a)  in  patients  (47.9±33.1  mg/dl)  was  also  higher  than
controls (11.7±7.6 mg/dl); p<0.01.
Hcy and Lp(a) levels were both significantly correlated
with the degree of retinal arteriosclerosis (Figure 1 and Figure
2).  In  multivariable  analysis,  retinal  arteriosclerosis  was
associated with higher levels of Lp(a) (OR: 1.13, 95% CI:
1.07-1.19; P<0.01) and Hcy (OR: 1.52; 95% CI: 1.31-1.77;
p<0.001). There was no statistically significant association of
retinal arteriosclerosis with age, systolic and diastolic blood
pressure, TC, TG, LDL-C, and HDL-C. However, there was
Figure 2. Relationship between Lp(a) level and the degree of retinal
arteriosclerosis. There was a direct linear correlation between Lp(a)
level and the degree of retinal arteriosclerosis in the study population
(r=0.61,  p<0.01),  i.e.  patients  with  higher  degree  of  retinal
arteriosclerosis had higher level of Lp(a)
a significant direct linear correlation between Lp(a) and Hcy
(Figure 3).
Consistent with previous reports [20,33], 30 mg/dl of
Lp(a) (likelihood ratio= 69.11, P<0.0001) and 15.5 μmol/l of
Hcy (likelihood ratio= 86.93, p<0.0001) were determined as
significant cutoff points for arteriosclerosis. Lp(a) and Hcy
performance  as  a  predictor  of  arteriosclerosis  was
summarized by receiver operating characteristic (ROC) curve
(Figure 4) and area under the curve (AUC; Table 3). ROC
curve was well above the diagonal, indicating good sensitivity
and  specificity.  The  AUC  indicated  a  high  probability  of
correctly prediction of arteriosclerosis.
DISCUSSION
Increased blood pressure, elevated total cholesterol, smoking
status, coronary bypass surgery history, and high white blood
cell  count  are  important  etiologic  factors  in  retinal
arteriosclerosis,  but  there  is  limited  information  about  a
possible role of Lp(a) and Hcy in the pathophysiology of
retinal arteriosclerosis [1,4,19]. It is well known that elevated
levels of Hcy and Lp(a) are often associated with endothelial
dysfunction and enhanced atherosclerosis [12,34]. Various
authors have proposed that hyperhomocysteinemia and high
serum  Lp(a)  concentrations  play  a  role  in  the  genesis  of
systemic atherosclerosis, thrombosis, and related disorders
[11,20,35,36].
The retina is the only place where we can directly observe
arteriosclerotic  changes  noninvasively  [1-3].  Since  both
cerebral and retinal arteries are peripheral branches of the
internal carotid arteries, high Lp(a) and Hcy levels may also
be associated with retinal vascular diseases such as retinal
Figure 3. Correlation of Hcy level with Lp(a) level. There was a direct
linear  correlation  between  Hcy  and  Lp(a)  levels  in  the  study
population (r=0.67, p<0.01), i.e., higher level of Hcy was associated
with higher level of Lp(a).
Molecular Vision 2008; 14:1692-1697 <http://www.molvis.org/molvis/v14/a200> © 2008 Molecular Vision
1694Figure  4.  Receiver  operating  characteristic  curves  for
arteriosclerosis.  Shown  is  the  relationship  of  sensitivity  to  1-
specificity as plotted for lipoprotein(a) and homocysteine. The area
under each receiver operating characteristic (ROC) curve for each
parameter indicates its diagnostic accuracy (Table 3).
arteriosclerosis [2,4,37]. To evaluate the connection between
Lp(a)  and  Hcy  levels  and  retinal  arteriosclerosis,  we
determined serum Lp(a) and Hcy concentrations and lipid and
lipoprotein  levels.  In  the  present  study,  patients  had
significantly higher Hcy and Lp(a) levels. These results are in
agreement with those reported by Martin et al., [38] who
suggested  Hcy  might  be  a  risk  factor  in  retinal  vascular
disease.  Present  study  findings  suggest  that
hyperhomocysteinemia may play an important role in the
pathogenesis of retinal arteriosclerosis.
Lp(a)  is  a  low-density  lipoprotein  particle  in  which
apolipoprotein B-100 is linked by a single interchain disulfide
bridge to a unique glycoprotein apo(a) [39,40]. It has been
shown that high plasma Lp(a) levels are closely associated
with arterial thrombosis such as myocardial infarction and
cerebral infarction [16,41,42]. The role of Lp(a) in retinal
vascular changes has been reported in a few cases [43-46].
Some investigators have proposed that impaired fibrinolysis
and atherogenesis induced by Lp(a) may play a role in the
pathophysiology  of  retinal  vascular  changes,  while  other
investigators have concluded that serum Lp(a) level is not a
significant risk factor for atherosclerosis of the retinal arteries
[44,45]. Foody et al. [20] found that thiols, such as Hcy, can
dissociate apo(a) from Lp(a) complex, leading to the exposure
of an additional lysine binding site on apo(a) that can increase
the affinity of apo(a) to plasmin-modified fibrin. In the present
study, correlations between Lp(a), Hcy, and the degree of
TABLE 2. LIPID PROFILES OF PATIENTS WITH RETINAL ARTERIOSCLEROSIS AND CONTROLS
Variables
 Controls
   (n=54)
mean±SD
 Patients
  (n=80)
mean±SD p value
TC (mg/dl) 159.4±25.2 199.8±39.6 <0.0001*
TG (mg/dl) 114.8±35.3 152.4±71.8 0.001**
HDL-C (mg/dl) 37.4±9.5 39.7±8.6 >0.1*
LDL-C (mg/dl) 99.5±22.9 129.6±37.8 <0.0001*
This table shows the comparison of the lipid profiles between the patients and controls. Except the high-density lipoprotein
cholesterol  (HDL-C) level, all the total cholesterol (TC), triglyceride (TG), and low-density lipoprotein cholesterol (LDL-C)
levels are higher in patients than controls. The asterisk denotes an independent-sample  t-test, and the double asterisk indicates
a Mann-Whitney U test.
TABLE 3. AREA UNDER THE CURVE FOR THE RECEIVER OPERATING CHARACTERISTIC CURVES IN FIGURE 4
Test result
 variables
 Area
under
curve
Standard
    error
Asymptotic
        sig.
Asymptotic 95%
confidence interval
Lower                  Upper
bound                  bound
Lipoprotein(a) 0.888 0.027 0.000 0.835 0.941
Homocysteine 0.950 0.017 0.000 0.917 0.983
This table shows the values of area under the curve for the receiver operating characteristic curves of lipoprotein (a) and
homocysteine in Figure 4.
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1695retinal  arteriosclerosis  were  also  investigated.  The  data
indicate that there is a significant correlation between the
degree of retinal arteriosclerosis with both Lp(a) and Hcy
levels. Moreover, a significant correlation between Lp(a) and
Hcy  concentrations  was  observed.  However,  because  this
study  only  included  male  participants  and  the  study
population was of a low number, further studies are warranted.
In conclusion, our findings support the idea that Lp(a) and
Hcy may play an important role in the development of retinal
arteriosclerosis.
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